A higher level of STING was found in liver tissues from NAFLD patients, in mice model of NAFLD, STING-induced macrophage-mediated liver inflammation and fibrosis, whereas STING deficiency attenuated steatosis, fibrosis, inflammation, and insulin resistance in the liver of mice [85]. The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.